Display options
Share it on

Med Mycol Case Rep. 2013 Mar 14;2:79-84. doi: 10.1016/j.mmcr.2013.02.008. eCollection 2013 Mar 14.

Mind the gap: Management of an emergent and threatening invasive fungal infection-a case report of rhino-orbital-cerebral and pulmonary mucormycosis.

Medical mycology case reports

Joana Cortez, Bruno Costa Gomes, Andrea Speidel, Conceição Peixoto, Elina Selicka, Cristina Valente, Paulo Figueiredo, António Vieira

Affiliations

  1. Infectious Diseases Department, Coimbra's Hospital Centre and University (Centro Hospitalar e Universitário de Coimbra), General Hospital, Coimbra 3041-801, Portugal.
  2. Neuroradiology Department, Coimbra's Hospital Centre and University (Centro Hospitalar e Universitário de Coimbra), General Hospital, Coimbra 3041-801, Portugal.
  3. Otorhinolaringology Department, Coimbra's Hospital Centre and University (Centro Hospitalar e Universitário de Coimbra), General Hospital, Coimbra 3041-801, Portugal.
  4. Infectious Diseases Department, Riga Eastern Clinical University Hospital, Infectology Centre of Latvia, Riga, Latvia.
  5. Pathology Department, Portuguese Oncology Institute (Instituto Português de Oncologia), Coimbra 3000-075, Portugal.

PMID: 24432223 PMCID: PMC3885946 DOI: 10.1016/j.mmcr.2013.02.008

Abstract

Mucormycosis is an emergent and threatening invasive fungal invasion underdiagnosed by clinicians due to lack of awareness and aspecific clinical picture. The authors describe a clinical case of a diabetic and cirrhotic patient who developed rhino-orbital-cerebral and pulmonary mucormycosis, non-responsive to treatment. Typical gaps in the management of this deadly disease are addressed. There is a strong need for novel therapies and an expectation that sponsors will recognize the critical need for randomized clinical trials.

Keywords: Delays; Diabetes; High mortality; Hyperbaric medicine; Mucormycosis; Randomized clinical trials

References

  1. Antimicrob Agents Chemother. 2011 Apr;55(4):1768-70 - PubMed
  2. Emerg Infect Dis. 2009 Sep;15(9):1395-401 - PubMed
  3. Clin Infect Dis. 2008 Aug 1;47(3):364-71 - PubMed
  4. Med Mycol. 2012 Aug;50(6):611-8 - PubMed
  5. Clin Microbiol Infect. 2009 Oct;15 Suppl 5:60-5 - PubMed
  6. Pharmacotherapy. 2013 Jan;33(1):e1-8 - PubMed
  7. Clin Infect Dis. 2005 Sep 1;41(5):634-53 - PubMed
  8. Clin Infect Dis. 2006 Apr 1;42(7):e61-5 - PubMed
  9. Lancet Infect Dis. 2011 Apr;11(4):301-11 - PubMed
  10. Antimicrob Agents Chemother. 2006 Jan;50(1):96-103 - PubMed
  11. J Neurosci Nurs. 1995 Jun;27(3):174-81 - PubMed
  12. J Antimicrob Chemother. 2012 Mar;67(3):715-22 - PubMed
  13. Clin Infect Dis. 2012 Feb;54 Suppl 1:S55-60 - PubMed
  14. Crit Rev Microbiol. 2013 Aug;39(3):310-24 - PubMed
  15. Rev Neurol. 2001 Nov 16-30;33(10):951-3 - PubMed
  16. Haematologica. 2013 Apr;98(4):492-504 - PubMed
  17. Clin Microbiol Infect. 2005 Jul;11(7):515-7 - PubMed
  18. Clin Infect Dis. 2008 Aug 15;47(4):503-9 - PubMed
  19. Emerg Med Clin North Am. 2008 May;26(2):571-95, xi - PubMed
  20. Case Rep Med. 2011;2011:830769 - PubMed
  21. Diabetes Metab. 2012 Jun;38(3):193-204 - PubMed
  22. Clin Infect Dis. 2012 Feb;54 Suppl 1:S79-85 - PubMed
  23. Mycopathologia. 2012 Dec;174(5-6):499-504 - PubMed
  24. Clin Infect Dis. 2012 Feb;54 Suppl 1:S73-8 - PubMed
  25. J Clin Microbiol. 2011 Jun;49(6):2151-3 - PubMed
  26. Biol Blood Marrow Transplant. 2009 Aug;15(8):991-5 - PubMed
  27. Rev Invest Clin. 2004 Jan-Feb;56(1):51-5 - PubMed
  28. Curr Infect Dis Rep. 2012 Aug;14(4):423-34 - PubMed
  29. Clin Infect Dis. 2012 Feb;54 Suppl 1:S23-34 - PubMed
  30. J Pediatr Hematol Oncol. 2010 Mar;32(2):131-3 - PubMed

Publication Types